Drug Trends Part Two: Evaluating In-Network and Out-Of-Network Trends

Each year the Mitchell Pharmacy Solutions Drug Trends Series analyzes the state of pharmacy trends in workers' comp. In part two of our series, we evaluated combined in- and out-of-network channels.

Infographic Summary

Part two of our analysis features trends experienced within our combined in- and out-of-network channels to address the total view of prescription activity. From a percentage perspective, in-network still represents the majority with over 80% of the prescriptions filled, with out-of-network representing less than 20%, indicating pharmacy management programs continue to positively influence prescription utilization. Find out more in our infographic.

If you missed any of our drug trends series, be sure to visit the drug trends page for previous reports, short videos, and more.

View this and future installments of our drug trends series here.



To view future installments of our drug trends series, click here.

Enlyte is the parent brand of Mitchell | Genex | Coventry, a leader in cost-containment technology, independent medical exams (IME), provider and specialty networks, case management services, pharmacy benefit and disability management. The three businesses have recently aligned their joint industry expertise and advanced technology solutions into a combined organization of nearly 6,000 associates committed to simplifying and optimizing property, casualty and disability claims processes and services.

More from Risk & Insurance

More from Risk & Insurance